Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Aug 14, 2008; 14(30): 4834-4837
Published online Aug 14, 2008. doi: 10.3748/wjg.14.4834
Published online Aug 14, 2008. doi: 10.3748/wjg.14.4834
Table 2 Outcomes and associated risk factors for TACE in the patients with CLE
| Doses of lipiodol (mL) | Tumor size | Pulmonary embolism | Injection artery of lipiodol | Recovery time (wk) | Reference |
| 35 | ND | (+) | ND | 3 | 8 |
| 8 | ND | (+) | ND | 3 | 8 |
| ND | ND | (+) | ND | 2 | 8 |
| 15 | 10 cm × 14 cm | (+) | RIPA, RMA | 2 | 9 |
| ND | Large | (+) | RIPA | 6 | 7 |
| Hepatic proper artery | |||||
| Epicholedocal artery | |||||
| 12 | Large | (-) | RCA, RHA, MHA | Death | 10 |
| 30 | 10 cm × 15 cm | (+) | RIPA, RHA | 6 | Present case |
- Citation: Choi CS, Kim KH, Seo GS, Cho EY, Oh HJ, Choi SC, Kim TH, Kim HC, Roh BS. Cerebral and pulmonary embolisms after transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2008; 14(30): 4834-4837
- URL: https://www.wjgnet.com/1007-9327/full/v14/i30/4834.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.4834